*

Honorable Donald P. Lay, Senior U.S. Circuit Judge for the Eighth Circuit, sitting by

designation. 

United States Court of Appeals,

Eleventh Circuit.

No. 95-9418.

In re T2 MEDICAL, INC. SHAREHOLDER LITIGATION.

Kenneth and Laura BENDER, Hal Bloomberg, Arnold Brustin, Jonathan Burstein, Margaret C.

Carnett, et al., Plaintiffs-Appellants,

v.

Joseph C. ALLEGRA, T2 Medical, Inc., David Hersh, J. Lee Ledbetter, Defendants-Appellees,

David Sachs, Objector, pro se; Richard A. Lawrence; Coram Healthcare Corporation, Movants.

Dec. 8, 1997.

Appeal from the United States District Court for the Northern District of Georgia. (NO. 1:94-CV744-RLV) Robert L. Vining, Judge.

Before HATCHETT, Chief Judge, ANDERSON, Circuit Judge, and LAY*

, Senior Circuit Judge.

HATCHETT, Chief Judge:

Appellants, class members of a federal securities lawsuit that concluded in a settlement,

moved, after final judgment had been entered, "to enforce" the settlement agreement, asserting

state-law claims against appellees for alleged misconduct occurring during the period of the

settlement negotiations. The district court, finding that appellants' motion constituted a

contractually-prohibited attempt to modify the settlement agreement, held that it had "no authority

or jurisdiction" to entertain it. We affirm.

BACKGROUND

On August 24, 1994, the district court in the Northern District of Georgia certified a class
 1

In July 1994, T2 merged with other companies to form appellee Coram Healthcare Corp.

(Coram). The parties agree that for purposes of this lawsuit Coram is the successor in interest to

T2

. The individual appellees served as officers of T2. 

 2Pursuant to paragraph 2.3, the adjusted exercise price of the warrants was derived from an

agreed-upon initial exercise price of $20.25 that was adjusted "based on the average closing

price for Coram common stock for the ten business days preceding the date at which the

Judgment has become Final." Pursuant to the stipulation, the judgment became "Final" on

Saturday, June 17, 1995, "thirty (30) days after entry of the Judgment," and thus the ten-day

adjustment period transpired June 5-9 and 12-16, 1995. The warrants have a four-year term from

their date of issuance. 

of persons (appellants) who purchased T2 Medical, Inc. (T2) common stock from December 2, 1991,

through August 12, 1993, and "suffered damages as a result thereof."1 Less than two months later,

the parties executed a memorandum of understanding which memorialized the material terms of a

settlement.

In April 1995, the parties filed a stipulation of settlement with the district court. The

stipulation provides that appellants release and discharge all claims against appellees in exchange

for $25,000,000 and 2,520,000 warrants to purchase Coram common stock. The adjusted exercise

price of the warrants, calculated pursuant to a formula outlined in paragraph 2.3 of the stipulation,

was $22.125.2 Paragraph 9.7 of the stipulation states that

[t]his Stipulation of Settlement ... shall not be subject to limitation, impairment,

modification, or termination for any reason ..., including without limitation the following:

(a) Any judicial ... decision ... of any type which allegedly relates to any of the terms

of this settlement or to any issue, claim, allegation or defense which has been or

might have been asserted in the Litigation;

(b) Any change, whether adverse or positive, in the financial condition, assets,

liabilities, business, or any other corporate ... activity of any of the Parties;

(c) Any allegedly newly discovered facts, legal issues, events or allegations of any

type which allegedly relate to any of the terms of this settlement ...; or

(d) Any other action or conduct of any type which allegedly relates to any of the

terms of this settlement....
 3

Appellees represent, and appellants do not dispute, that "Coram caused $25 million to be

transferred to Plaintiffs' escrow agent, and also issued and transferred 2,520,000 warrants

convertible to Coram common stock at the negotiated exercise price to Plaintiffs' escrow agent." 

Paragraph 10.7 of the stipulation provides that the stipulation and its exhibits "constitute the entire

agreement among the parties hereto and no representations, warranties or inducements have been

made to any party concerning the Stipulation ... other than the representations, warranties and

covenants contained and memorialized in such documents." Paragraph 10.10 of the stipulation

reads: "The Court shall retain jurisdiction with respect to implementation and enforcement of the

terms of the Stipulation, and the Settling Parties hereto submit to the jurisdiction of the Court for

purposes of implementing and enforcing the settlement embodied in the Stipulation."

After conducting a fairness hearing, on May 19, 1995, the district court, in a Final Judgment

and Order of Dismissal, approved the "settlement set forth in the Stipulation," and "direct[ed] that

it ... be effectuated in accordance with its terms." The court also wrote:

Without affecting the finality of this Judgment in any way, this Court hereby retains

continuing jurisdiction over (a) implementation and administration of the settlement; (b)

distribution of the Settlement Fund; (c) determination of any questions or applications for

attorneys' fees, costs, interest, and expenses; (d) determination of any other applications for

payments out of the Settlement Fund; and (e) all parties heretofore [sic] the purpose of

enforcing and administering the Stipulation and Exhibits thereto and the Litigation until the

Judgment contemplated hereby has become effective and each and every act agreed to be

performed by the parties has been performed pursuant to the Stipulation.

Thereafter, the conditions of settlement were fulfilled.3

Appellants allege that "[d]uring the pendency of the settlement, Coram made numerous,

materially false and misleading announcements to the investing public regarding its business

ventures and financial status, which inflated the market price of its common stock." These

announcements related to the following business activity: In January 1995, Coram announced it

would merge with Caremark International; on April 6, 1995, Coram reported the completion of this
 4

On August 11, 1995, Coram announced a second-quarter loss of $66,300,000. 

acquisition; and on April 18, 1995, Coram announced a merger agreement with Lincare. According

to appellants,

[i]n early June of 1995, Coram learned that its analysis regarding the value of the

consummated Caremark merger was grossly erroneous. As a consequence of this discovery,

the pending merger with Lincare was terminated. However, these facts were not disclosed

to the plaintiffs or the investing public until late July and early August. Thus, at the very

time that plaintiffs and defense counsel were determining the exercise price of the Warrants

under the terms of the Stipulation, the defendants knew that the value of the Coram stock

(which was used to establish th[e] exercise price ... ) was grossly inflated.

....

Had the plaintiffs and the investing public known of the materially adverse

information concealed by Coram, the average market price of Coram common stock during

the Adjustment Period would have been approximately $5.25 per share, resulting in an

Adjusted Exercise Price of approximately $6.30 per share. Instead, on August 11, 1995, the

truth surrounding Coram's financial condition was revealed, and the price of Coram common

stock fell dramatically, virtually destroying the value of the Warrants and revealing Coram's

breach of its obligations under the Stipulation.

Appellants' Br. at 6-8.4

On August 29, 1995, appellants filed a Motion to Enforce Stipulation of Settlement (motion

to enforce), alleging, without any accompanying evidentiary support: (1) breach of the covenant of

good faith and fair dealing under Georgia law; (2) appellees' commission of fraud upon the court;

and (3) the doctrine of mutual mistake of fact under Georgia law. Appellants requested the

following relief:

[P]laintiffs move this Court to declare that Coram is in breach of the Stipulation and award

the plaintiffs the appropriate measure of damages reflecting the difference in value between

2,520,000 warrants with an exercise price of $20.[25] with Coram at a stock value of $18.50

(the value the day the Settlement Order became Final as defined in the Stipulation) and the

same number of warrants in Coram at the same exercise price with Coram at a stock value

of $5.25 (the closing price on August 14, 1995, the day following Coram's August 11

announcement).

In the alternative, plaintiffs move this Court for a decree of specific performance of
 5

"Unsure of the outcome of this appeal as to whether the district court possessed jurisdiction

to enforce the Stipulation," Appellants' Br. at 4 n.5, the warrant holders filed a separate lawsuit

against Coram and its officers in the Northern District of Georgia on November 21, 1995,

asserting claims for violations of (1) section 10(b) of the Securities Exchange Act of 1934 (the

1934 Act), 15 U.S.C. § 78j(b), and Rule 10b-5, 17 C.F.R. § 240.10b-5; (2) section 20(a) of the

1934 Act, 15 U.S.C. § 78t(a); (3) O.C.G.A. § 10-5-12(a)(2) (unlawful securities practices); (4)

O.C.G.A. § 51-6-4 (fraud by silence); and (5) the implied covenant of good faith and fair

dealing. In February 1997, the district court dismissed the action pursuant to Federal Rule of

Civil Procedure 12(b)(6). According to the court, the warrant holders' claims "essentially

involve[d] fraud in the inducement of the Stipulation." Hall v. Coram Healthcare Corp., Civ.

Action No. 1:95-cv-2994-WBH, slip op. at 9 n.6 (N.D.Ga. Feb. 13, 1997). After reciting

paragraph 10.7 of the stipulation, the court stated that

[u]nder Georgia state law, merger clauses are enforceable and may prevent a party

the terms of the Stipulation entailing the delivery of new warrants with an Adjusted Exercise

Price which is calculated using an Effective Price that accurately reflects the true value of

Coram during the Adjustment Period.

Finally, in the event that the Court disagrees with the Plaintiffs' assertion that the

false reports disseminated by Coram and its agents were the product of a fraudulent scheme

to inflate the Adjusted Exercise Price, the law of mutual mistake of fact provides a basis

upon which this Court can remedy the destruction of the value of the warrants and effectuate

the clear intent of the Stipulation by reforming the Stipulation to provide for an Adjusted

Exercise Price which reflects the true value of Coram during the Adjustment Period.

In an Order filed October 12, 1995, the district court denied appellants' motion, holding:

Despite the clear language of Paragraph 9.7, the plaintiffs seek to have this court modify the

Stipulation agreed to by the parties.1

This court has no authority or jurisdiction to consider the plaintiffs' motion because

there is nothing left to "enforce" with respect to the Stipulation. Additionally, the very terms

of the Stipulation, as set out in paragraph 9.7, prohibit the plaintiffs from seeking the kind

of modification they now desire. The fact that the value of the warrants received by the

plaintiffs has decreased provides no basis for this court [to] change the terms agreed upon

by the parties after extensive and intensive negotiations by able counsel.

In footnote 1, the court noted that "[t]he plaintiffs' attempt to characterize their motion as a motion

to "enforce' is unavailing. The court will certainly enforce the Stipulation, including the terms

included in Paragraph 9.7."

Appellants filed a notice of appeal on November 3, 1995.5

 On November 28, 1995, appellees
from recovering for fraud in the inducement of a contract. If a contract contains a

merger or "entire agreement" clause and the injured party seeks damages on the

contract rather than rescission, then the clause will prevent recovery by estopping

the claimant from asserting reliance on any misrepresentations (or omissions)

allegedly made outside of the four corners of the contract.

Hall, slip op. at 9 (footnote omitted). The court applied the Georgia rule to the federal

common law context and found that because "plaintiffs show[ed] no statements within

the Stipulation by which they were defrauded," their federal securities claims could not

survive defendants' motion. Hall, slip op. at 10. The court then declined to entertain the

warrant holders' supplemental state-law claims. Hall, slip op. at 10-11. The warrant

holders have appealed the district court's judgment in Hall in case number 97-8246, and

this court denied their subsequent motion to consolidate that appeal with the instant one. 

filed a motion to dismiss the appeal for lack of appellate jurisdiction, which this court ordered

carried with the case.

DISCUSSION

 A district court's determination that it lacked subject matter jurisdiction constitutes a

question of law that we review de novo. Fleming Cos. v. Abbott Lab. (In re Infant Formula Antitrust

Litig., MDL 878), 72 F.3d 842, 842-43 (11th Cir.1995).

The prescriptions of the Supreme Court's unanimous decision in Kokkonen v. Guardian Life

Insurance Co. of America, 511 U.S. 375, 114 S.Ct. 1673, 128 L.Ed.2d 391 (1994), control this case.

In Kokkonen, the parties settled a federal lawsuit based on diversity jurisdiction involving state-law

claims and counterclaims. Pursuant to Federal Rule of Civil Procedure 41(a)(1)(ii), the parties

executed a Stipulation and Order of Dismissal With Prejudice, which the district judge signed.

Subsequently, the parties disagreed about Kokkonen's obligation to return certain files under the

settlement agreement. Guardian Life moved to enforce the agreement, and Kokkonen opposed the

motion, arguing, in part, that the district court lacked subject matter jurisdiction. The Ninth Circuit

ultimately rejected Kokkonen's argument, holding that the district court retained jurisdiction under

its inherent supervisory power. Kokkonen, at 376-78, 114 S.Ct. at 1674-75.
In reversing, the Supreme Court made clear that "[e]nforcement of [a] settlement agreement

... is more than just a continuation or renewal of the dismissed suit, and hence requires its own basis

for jurisdiction." Kokkonen, at 378, 114 S.Ct. at 1675-76. In response to Guardian Life's assertion

that ancillary jurisdiction supported its position, the Court addressed its precedents concerning the

doctrine and concluded that none "has, for purposes of asserting otherwise nonexistent federal

jurisdiction, relied upon a relationship so tenuous as the breach of an agreement that produced the

dismissal of an earlier federal suit." Kokkonen, at 379, 114 S.Ct. at 1676. The Court recognized that

it had asserted ancillary jurisdiction in "two separate, though sometimes related," instances: "(1)

to permit disposition by a single court of claims that are, in varying respects and degrees, factually

interdependent, and (2) to enable a court to function successfully, that is, to manage its proceedings,

vindicate its authority, and effectuate its decrees." Kokkonen, at 379-80, 114 S.Ct. at 1676 (citations

omitted). The Court found that neither instance matched the circumstances before it. With regard

to the second, which is pertinent to this case, the Court stated:

We think ... that the power asked for here is quite remote from what courts require in order

to perform their functions.... [T]he only order here was that the suit be dismissed, a

disposition that is in no way flouted or imperiled by the alleged breach of the settlement

agreement. The situation would be quite different if the parties' obligation to comply with

the terms of the settlement agreement had been made part of the order of dismissal—either

by separate provision (such as a provision "retaining jurisdiction" over the settlement

agreement) or by incorporating the terms of the settlement agreement in the order. In that

event, a breach of the agreement would be a violation of the order, and ancillary jurisdiction

to enforce the agreement would therefore exist.

Kokkonen, at 380-81, 114 S.Ct. at 1677.

 We believe that the district court properly determined that it lacked jurisdiction to entertain

appellants' motion. In our view, appellants' misdenominated "motion to enforce" seeks a

modification of the settlement agreement because it requests compensation pursuant to an adjusted

exercise price for the warrants that differs from the one generated by the formula in the stipulation.
 6

At oral argument, appellants' counsel expressly disavowed that the motion to enforce was

one arising under Federal Rule of Civil Procedure 60(b). 

 7Appellees' motion to dismiss this action for want of appellate jurisdiction is denied. 

As the district court correctly held, it did not retain jurisdiction, pursuant to paragraph 9.7 of the

stipulation, over a party's attempted modification of the settlement. Accordingly, the court had no

authority to exercise ancillary jurisdiction over appellants' motion. Because appellants have not

urged that any other provision of law enabled the district court to exercise jurisdiction, we affirm

the district court's judgment .6

AFFIRMED.7

ANDERSON, Circuit Judge, dissenting:

I respectfully disagree with the district court's, and the majority's, characterization of the

appellants' motion as one to modify. I agree with appellants that their motion is properly construed

as one to enforce the settlement agreement. The agreement specified that the price of appellants'

warrants would be adjusted depending upon the price of Coram stock at a specified future date,

which turned out to be June 5-9, 1995, and June 12-16, 1995 (the measuring period). Part and parcel

of the settlement agreement was the duty of good faith imposed by Georgia law. Appellants alleged,

and in the posture of this case we must assume their allegations to be true, that defendants at that

relevant early June time knew certain facts which meant that the price of Coram stock was grossly

inflated as of the crucial June 5-9 and June 12-16, 1995, measuring period. Assuming appellants'

allegations to be true, as we must, defendants would have had a duty to disclose such information

to the public, and the price of Coram stock would have fallen dramatically during the measuring

period, rather than later in August when the information was actually disclosed. More significantly,

the settlement agreement as supplemented by the Georgia law duty of good faith required disclosure
of such information to the appellants; and the duty of good faith was breached by defendants when

they concealed such information for the purpose of artificially inflating the price of the stock during

the measuring period. In other words, the defendants breached the settlement agreement as written,

including the duty of good faith which was part and parcel thereof. Respectfully, I disagree with

the conclusion of the district court, and the majority, that appellants sought to modify the settlement

agreement, rather than to enforce same.

Having established that appellants' effort is to enforce the settlement agreement, I conclude

that the district court had jurisdiction. The district court expressly retained "continuing jurisdiction

over...(e) all parties hereto...[for] the purpose of enforcing" the settlement agreement. District

Court's May 19, 1995, Final Judgment and Order of Dismissal at 8, ¶12. In Kokkonen v. Guardian

Life Ins. Co of America, 511 U.S. 375, 380-82, 114 S.Ct. 1673, 1677, 128 L.Ed.2d 391 (1994), the

Supreme Court held on the facts there that a district court did not have jurisdiction to enforce a

settlement agreement. However, the Supreme Court expressly recognized that the district court

would have had jurisdiction if it had retained jurisdiction to enforce the agreement:

The situation would be quite different if the parties' obligation to comply with the terms of

the settlement agreement had been made part of the order of dismissal—either by separate

provision (such as a provision "retaining jurisdiction over the settlement agreement").... In

that event, a breach of the agreement would be a violation of the order, and ancillary

jurisdiction to enforce the agreement would therefore exist.

Id. at 381, 114 S.Ct. at 1677.

Accordingly, I dissent.